Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 39 Issue 9, September 2021

Volume 39 Issue 9

MAQC-IV and Sequencing Quality Control 2

SEQC2, the final phase of the MAQC consortium, presents the results of several sequencing benchmarking analyses.

SeeEditorial

Image: Ning Zhang, TopEdit Author Services. Cover Design: Erin Dewalt

Editorial

  • Editorial |

    The Sequencing Quality Control 2 (SEQC2/MAQC-IV) project provides resources to aid sequencing reproducibility and highlights factors that can guide platform and software choice.

News

Bioentrepreneur

    Building a Business

  • Building a Business |

    A historical analysis of oncology deals can help bioentrepreneurs navigate the right time for partnerships and exits and can inform on the type of investors likely to be interested.

    • Christiaan M. de Bloeme
    • Robin W. Jansen
    • Ernst-Jan Geutjes

Correspondence

Comment

  • Comment |

    The MicroArray Quality Control consortium—a 16-year international effort led by the FDA and involving hundreds of scientists from academia, industry and government—helped make genomic medicine a reality.

    • Marc Salit
    • Janet Woodcock

Features

    Patents

  • Patents |

    A study of the seasonality and overall quantity and quality of Chinese patenting, including international comparisons, suggests that government planning and annual targets encouraged gaming of the system, which increased patent counts but negatively affected patent quality.

    • Zhen Sun
    • Zhen Lei
    • Taoxiong Liu
  • Patents |

    Recent patents relating to methods of making and using organoids.

News & Views

Research

Careers & Recruitment

    Career Feature

  • People

  • People |

    Recent moves of note in and around the biotech and pharma industries.

Search

Quick links